Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019158 (
hepatitis
)
30,205
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Suppressor of cytokine signaling 3
(
SOCS3
), a negative-feedback molecule for cytokine signaling, has been implicated in protection against liver injury. Previous studies have shown that overexpression of
SOCS3
in the liver by adenovirus or membrane permeable recombinant protein protected the liver from various injuries. However it remained uncertain in which type of cells
SOCS3
suppresses liver injury. In this study, we demonstrated that forced expression of
SOCS3
in T and NKT cells suppressed ConA-induced
hepatitis
using T and NKT cell-specific
SOCS3
transgenic (Lck-
SOCS3
Tg) mice. IFN-gamma and IL-4 production was reduced in Lck-
SOCS3
Tg mice as well as splenocytes treated with ConA. IFN-gamma and IL-4 levels were also reduced in Lck-
SOCS3
Tg mice administrated with alpha-galactosylceramide, suggesting that
SOCS3
in NKT cells has suppressive function. Sustained expression of
SOCS3
in an NKT cell line also resulted in reduced expression of various cytokines and transcription factors. In contrast, T and NKT cell-specific
SOCS3
conditional knockout (Lck-
SOCS3
cKO) mice were hypersensitive to ConA-mediated
hepatitis
. Isolated
SOCS3
-deficient NKT cells produced higher levels of IFN-gamma and IL-4. These data indicate that
SOCS3
plays a negative regulatory role in NKT cell activation and that forced expression of
SOCS3
in NKT cells is effective in preventing
hepatitis
.
...
PMID:SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis. 1991 50